Externally‐Led Patient‐Focused Drug Development Meeting (EL‐PFDD) for Dementia with Lewy Bodies—DLB: Voices of Lived Experience on Life with Lewy and Unmet Treatment Needs

Abstract

Background: Dementia with Lewy bodies (DLB) is a prevalent form of dementia associated with neuronal alpha‐synuclein aggregates (Lewy bodies). Symptoms include cognitive impairment, fluctuations, neuropsychiatric features including psychosis, sleep disorders, and dysautonomia.

The paper